ArticleRadiation oncology (London, England)2023

G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells.

Meryem H Cetin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.